NCT00001335View on ClinicalTrials.gov

New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma

PHASE2CompletedINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

April 30, 1993

Study Completion Date

January 31, 2002

Conditions

Ewing's SarcomaNeuroblastomaRhabdomyosarcoma

Interventions

DRUG

ADR-529

DRUG

Topotecan

DRUG

G-CSF

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH